Bringing up peptides with a clinician can feel uncertain, especially when much of what you read online comes from vendors rather than pharmacies. This piece is not about how to persuade a doctor. It is about walking in informed on the things that actually determine whether a peptide is available to you legally, what it will cost, and whether the provider offering it is legitimate.
The four compounds often raised in these conversations sit in very different regulatory positions. Knowing which is which saves time and helps you ask better questions.
Where each compound stands
Semaglutide and tirzepatide are the GLP-1 medicines you have probably heard about. Both are FDA approved as branded products with specific approved uses. That approval matters because it means a licensed clinician can prescribe the brand-name drug, and a licensed pharmacy can dispense it. Compounded versions have been a separate story tied to shortage status, which the FDA has updated over time, so the compounding picture can change. Ask any provider directly whether they are offering the approved product or a compounded preparation, and under what basis.
Tesamorelin is FDA approved for a specific, narrow indication and is available by prescription through licensed pharmacies. Anything beyond its approved use is off-label, which is legal for a clinician to consider but worth naming plainly in your conversation.
Thymosin-alpha-1 is not FDA approved in the United States. You may see it discussed by clinics, but it does not carry the same standing as the approved products above. Treat claims about it with more caution and ask what legal basis a provider has for offering it.
The only legitimate purchase channel
A prescription written by a licensed clinician and filled by a licensed pharmacy is the path that keeps you inside the law and inside a system with accountability. Websites selling peptides labeled for research use only are not that path. They are not pharmacies, they do not dispense against a prescription, and products sold that way are not intended for human use regardless of how the site is marketed.
When you compare providers, the first filter is simple. Is there a real prescriber involved, and is the product coming from a state-licensed pharmacy or an FDA-registered outsourcing facility? If a service cannot answer that clearly, that is your answer.
What drives the cost
Price varies for reasons worth understanding before you sign up. Branded approved drugs are priced by their manufacturers, and insurance coverage depends heavily on the approved indication and your plan. Compounded preparations are priced differently and are not typically covered by insurance. Telehealth services often bundle a membership or consultation fee on top of the medication, so the sticker price and the total cost are not the same thing.
Ask for an itemized breakdown. You want to see the medication cost, any consultation or membership fee, and shipping separated out, so you can compare providers on equal terms.
How to vet a provider
A few concrete checks tell you more than any marketing copy.
- Confirm there is a licensed clinician who evaluates you and is reachable for follow-up, not just an intake form.
- Ask which pharmacy fills the prescription and whether it is a 503A pharmacy or a 503B outsourcing facility.
- Request the total cost in writing, with fees separated from the medication.
- Ask directly whether the product is FDA approved, compounded, or neither, and get a straight answer.
If a provider is evasive on any of these, that itself is useful information. Legitimate services answer these questions without friction.
The bottom line for your appointment
Go in knowing that semaglutide, tirzepatide, and tesamorelin are approved products with defined legal pathways, that thymosin-alpha-1 is not FDA approved, and that a prescription filled by a licensed pharmacy is the only channel worth considering. This is general information, not medical advice. Decisions about whether any of these are appropriate for you belong with a licensed clinician who knows your history.